IBSA Choriomon 1 vial (1x 5000 IU)

HCG - human chorionic gonadotropin - Pregnyl

This non-steroid compound is prevalent in athletics. HCG, a natural protein hormone synthesized by the placenta, is purified from the urine of pregnant women.

This hormone closely mimics LH (Luetinising Hormone), triggering testosterone production in males by acting on the Leydig cells in the testes. While primarily prescribed for women with specific ovarian disorders, HCG is utilized by men experiencing hypogonadism. Athletes leverage HCG to boost natural testosterone levels, which may decline due to prolonged steroid use. High steroid dosages can send misleading signals to the hypothalamus, leading to reduced testicular responsiveness and potential atrophy. To counteract this, athletes use HCG for signaling the testes continually, preventing atrophy.

Upon administration, HCG rapidly elevates serum testosterone, with initial increases observable about two hours after injection. A second spike presents in two to four days. HCG therapy effectively prevents testicular atrophy while enhancing plasma testosterone levels during training cycles. Some steroid users report optimal gains in strength and size when combining HCG with steroids, potentially due to elevated natural androgen levels alongside synthetic hormones. Though an ideal dosage for athletes is not firmly established, a weekly administration of 1000 to 2000 IU is often recommended, with cycles limited to three weeks followed by at least a month off.

For instance, HCG may be deployed for two to three weeks mid-cycle and again towards the end. Prolonged usage is speculated to suppress natural gonadotropin production, thus short cycles are advisable. Side effects may include gynecomastia, fluid retention, elevated libido, mood swings, headaches, and increased blood pressure. HCG can raise male androgen levels by up to 400%, concurrently increasing estrogen levels, which can lead to gynecomastia if dosages exceed individual tolerances. Other side effects include nausea and vomiting.

No overdose incidents have been reported with HCG, nor are there any associations with carcinomas or renal impairment. Initially, HCG was investigated for potential AIDS virus transmission due to its biological activity, but this has been ruled out. Athletes utilize HCG to mitigate challenges stemming from abrupt cessation of steroid cycles. Additionally, it remains undetectable in steroid tests, making it a favored option to maintain high androgen levels ahead of competitions with drug screenings. After mixing, HCG requires refrigeration and lasts approximately 10 weeks, administered intramuscularly. It is primarily obtainable via physician prescription for those presenting symptoms of hypogonadism. Sourcing HCG on the black market is challenging.

Pregnyl for Pregnancy:

Pregnyl, or human chorionic gonadotropin (hCG), is a highly purified solution derived from the urine of pregnant women. Administering it intramuscularly triggers the natural mid-cycle LH surge, facilitating ovulation. For maximum pregnancy chances, daily intercourse is recommended for 48 hours following the LH surge.

Your doctor will provide guidance on optimal intercourse timing or may suggest artificial insemination procedures to enhance conception likelihood.

HOW ARE HUMEGON AND PREGNYL ADMINISTERED?

Humegon is delivered via intramuscular injection, typically in the buttock, as oral intake is non-viable due to protein digestion in the stomach. Injections are usually initiated within the first five days of the menstrual cycle and may continue daily for 7 to 12 days, with adjustments based on your treatment response. Physicians may modify dosage or schedule as necessary.

Pregnyl (chorionic gonadotropin for injection, USP) is injected intramuscularly when the physician assesses adequate stimulation has been achieved. In cases of over-response, administration may be deferred.

DURACIÓN DEL TRATAMIENTO

If conception does not occur, both Humegon and Pregnyl may be prescribed in subsequent menstrual cycles, although treatment cycles aren’t always consecutive, as therapies are tailored for each individual.

Therapy may extend across six cycles, after which alternative options will be considered.

¿FUNCIONA?

Upon successful ovulation, progesterone is secreted by the ovaries, measurable via blood tests roughly seven days post-ovulation.

If pregnancy does not occur, a menstrual period can be expected about 14 days after hCG injection. In the absence of a period, a blood test will confirm pregnancy, with ultrasound utilized to monitor pregnancy development.

CAREFUL MONITORING IS ESSENTIAL

Effective monitoring is crucial for treatment regulation and minimizing side effects. Two primary monitoring methods are employed, often in conjunction.

The first involves daily blood tests to evaluate estrogen levels, as developing follicles yield increasing estrogen quantities. Elevated estrogen reflects a robust ovarian response to Humegon (menotropins for injection).

The second method, ultrasound, employs sound waves to generate ovarian images, aiding healthcare professionals in assessing follicle quantity and size, thereby predicting ovulation timing. Complete participation in all tests and ultrasound evaluations is crucial, as their outcomes may necessitate treatment adjustments during cycles.

SIDE EFFECTS/OTHER CONCERNS RELATED TO TREATMENT

Humegon and Pregnyl (chorionic gonadotropin for injection, USP) can lead to both minor and severe adverse effects along with various risks. Important side effects and concerns should be openly discussed with your physician before commencing treatment.

Occasional swelling, irritation, and pain at the injection site may occur during Humegon therapy, along with headaches, abdominal pain, and mild to moderate ovarian enlargement. Should these symptoms arise, consult your doctor for treatment reassessment. Pregnyl injections may also induce pain at the injection site, alongside headache, irritability, restlessness, depression, fatigue, and fluid retention.

A notable concern with fertility medications like Humegon is the potential for multiple pregnancies. Approximately 80% of fertility drug-induced pregnancies result in single births, though twins are common, and triplets or more may occur in rare cases. Doctors should address multiple births risks before treatment initiation.

Ensure discussions about side effects and any treatment-related concerns with your doctor prior to starting therapy.

¿QUÉ EFICACIA TIENE HUMEGON (MENOTROPINAS INYECTABLES, USP)?

Humegon is effective in inducing ovulation among women experiencing irregular cycles or anovulation. Effectiveness varies based on infertility causes, with factors such as tubal status, semen quality, and patient age influencing pregnancy chances. Should you remain unpregnant while using Humegon, your doctor will evaluate alternative options.

CONCLUSIÓN

Numerous healthy babies are born annually thanks to fertility treatments, including Humegon and Pregnyl (chorionic gonadotropin for injection, USP). Your healthcare provider is available to address any additional inquiries you may have regarding these medications.